Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Creative Planning

Creative Planning raised its holdings in Doximity, Inc. (NASDAQ:DOCS) by 13.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,104 shares of the company’s stock after purchasing an additional 2,671 shares during the period. Creative Planning’s holdings in Doximity were worth $963,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. LRI Investments LLC acquired a new stake in Doximity in the first quarter valued at approximately $27,000. Blue Trust Inc. lifted its position in shares of Doximity by 621.4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after acquiring an additional 1,193 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after acquiring an additional 412 shares in the last quarter. Quarry LP lifted its position in shares of Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after acquiring an additional 131,253 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new position in shares of Doximity in the first quarter valued at approximately $46,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently commented on DOCS. Canaccord Genuity Group lifted their price objective on Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Morgan Stanley raised their target price on Doximity from $26.00 to $33.00 and gave the stock an “underweight” rating in a research note on Wednesday. Evercore ISI raised their target price on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. JPMorgan Chase & Co. lifted their price objective on Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a research note on Monday, August 19th. Finally, Truist Financial reaffirmed a “hold” rating and issued a $35.00 price objective (up from $31.00) on shares of Doximity in a research note on Wednesday, August 14th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $36.42.

Doximity Stock Performance

Doximity stock opened at $42.35 on Friday. Doximity, Inc. has a fifty-two week low of $20.28 and a fifty-two week high of $44.88. The company has a market capitalization of $7.86 billion, a P/E ratio of 52.94, a PEG ratio of 5.05 and a beta of 1.29. The stock has a 50-day simple moving average of $40.66 and a 200-day simple moving average of $32.33.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.16 by $0.06. The firm had revenue of $126.68 million during the quarter, compared to the consensus estimate of $119.88 million. Doximity had a return on equity of 19.26% and a net margin of 32.53%. As a group, analysts forecast that Doximity, Inc. will post 0.8 earnings per share for the current year.

Insider Buying and Selling at Doximity

In other Doximity news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the transaction, the chief financial officer now owns 309,627 shares in the company, valued at approximately $10,836,945. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, Director Watkin Phoebe L. Yang sold 1,011 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the sale, the director now owns 11,258 shares in the company, valued at $287,529.32. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the completion of the sale, the chief financial officer now owns 309,627 shares in the company, valued at approximately $10,836,945. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is owned by company insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.